Intricacies of the Molecular Machinery of Catecholamine Biosynthesis and Secretion by Chromaffin Cells of the Normal Adrenal Medulla and in Pheochromocytoma and Paraganglioma
Authors:
- Annika M.A. BerendsABAnnika M.A. Berends
- Graeme EisenhoferGEGraeme Eisenhofer
- Lauren FishbeinLFLauren Fishbein
- Anouk N.A. van der Horst-SchriversAHAnouk N.A. van der Horst-Schrivers
- Ido P. KemaIKIdo P. Kema
- Thera P. LinksTLThera P. Links
- Jacques W.M. LendersJLJacques W.M. Lenders
- Michiel N. KerstensMKMichiel N. Kerstens
Open Access
Abstract
The adrenal medulla is composed predominantly of chromaffin cells producing and secreting the catecholamines dopamine, norepinephrine, and epinephrine. Catecholamine biosynthesis and secretion is a complex and tightly controlled physiologic process. The pathways involved have been extensively studied, and various elements of the underlying molecular machinery have been identified. In this review, we provide a detailed description of the route from stimulus to secretion of catecholamines by the normal adrenal chromaffin cell compared to chromaffin tumor cells in pheochromocytomas. Pheochromocytomas are adrenomedullary tumors that are characterized by uncontrolled synthesis and secretion of catecholamines. This uncontrolled secretion can be partly explained by perturbations of the molecular catecholamine secretory machinery in pheochromocytoma cells. Chromaffin cell tumors also include sympathetic paragangliomas originating in sympathetic ganglia. Pheochromocytomas and paragangliomas are usually locally confined tumors, but about 15% do metastasize to distant locations. Histopathological examination currently poorly predicts future biologic behavior, thus long term postoperative follow-up is required. Therefore, there is an unmet need for prognostic biomarkers. Clearer understanding of the cellular mechanisms involved in the secretory characteristics of pheochromocytomas and sympathetic paragangliomas may offer one approach for the discovery of novel prognostic biomarkers for improved therapeutic targeting and monitoring of treatment or disease progression.Keywords
This publication has 253 references indexed in Scilit:
- Kinetic Analyses Guide the Therapeutic Decision in a Novel Form of Moderate Aromatic Acid Decarboxylase Deficiency2011
- Vesicular monoamine transporters: Structure‐function, pharmacology, and medicinal chemistryMedicinal Research Reviews, 2011
- Tyrosine hydroxylase and regulation of dopamine synthesisArchives of Biochemistry and Biophysics, 2011
- Unique biological function of cathepsin L in secretory vesicles for biosynthesis of neuropeptidesNeuropeptides, 2010
- RETRACTED ARTICLE: Carboxypeptidase E: Elevated Expression Correlated with Tumor Growth and Metastasis in Pheochromocytomas and Other CancersCellular and Molecular Neurobiology, 2010
- Mass Spectrometry-Based Neuropeptidomics of Secretory Vesicles from Human Adrenal Medullary Pheochromocytoma Reveals Novel Peptide Products of Prohormone ProcessingJournal of Proteome Research, 2010
- Human Tyrosine Hydroxylase Natural Allelic Variation: Influence on Autonomic Function and HypertensionCellular and Molecular Neurobiology, 2010
- Catestatin: A multifunctional peptide from chromogranin ARegulatory Peptides, 2010
- Revisiting the Stimulus-Secretion Coupling in the Adrenal Medulla: Role of Gap Junction-Mediated Intercellular CommunicationMolecular Neurobiology, 2009
- Deletion of the neuropeptide Y (NPY) Y1receptor gene reveals a regulatory role of NPY on catecholamine synthesis and secretionProceedings of the National Academy of Sciences, 2006